A clinical perspective of IL-1β as the gatekeeper of inflammation.
about
Diverse roles of macrophages in atherosclerosis: from inflammatory biology to biomarker discoveryFibrosis biomarkers in workers exposed to MWCNTsPlatelets in Pulmonary Immune Responses and Inflammatory Lung DiseasesA clear and present danger: inflammasomes DAMPing down disorders of pregnancyThe immunopathology of sepsis: pathogen recognition, systemic inflammation, the compensatory anti-inflammatory response, and regulatory T cellsGPER signalling in both cancer-associated fibroblasts and breast cancer cells mediates a feedforward IL1β/IL1R1 response.Stress-induced neuroinflammatory priming: A liability factor in the etiology of psychiatric disordersRole of the HIN domain in regulation of innate immune responsesThe impact of environmental metals in young urbanites' brains.Aryl hydrocarbon receptor (AhR) regulates silica-induced inflammation but not fibrosisNLRC4-driven production of IL-1β discriminates between pathogenic and commensal bacteria and promotes host intestinal defenseGold(I) complexes of 9-deazahypoxanthine as selective antitumor and anti-inflammatory agentsInflammation in Sickle Cell Disease: Differential and Down-Expressed Plasma Levels of Annexin A1 ProteinAnti-inflammatory properties of a novel peptide interleukin 1 receptor antagonistNeutrophil cell surface receptors and their intracellular signal transduction pathways.Inhibition of interleukin-1β decreases aneurysm formation and progression in a novel model of thoracic aortic aneurysms.Aromatase is required for female abdominal aortic aneurysm protection.Genetic and pharmacologic disruption of interleukin-1β signaling inhibits experimental aortic aneurysm formation.Naturally occurring genetic variants of human caspase-1 differ considerably in structure and the ability to activate interleukin-1β.Innate immune recognition of molds and homology to the inner ear protein, cochlin, in patients with autoimmune inner ear diseaseSex- and disease-specific inflammasome signatures in circulating blood leukocytes of patients with abdominal aortic aneurysm.Characterization of the Proinflammatory Profile of Synovial Fluid-Derived Exosomes of Patients with Osteoarthritis.An additional piece in the puzzle of neutrophil-derived IL-1β: the NLRP3 inflammasome.Resolvin D1 inhibits inflammatory response in STZ-induced diabetic retinopathy rats: Possible involvement of NLRP3 inflammasome and NF-κB signaling pathway.Safety and tolerability of canakinumab, an IL-1β inhibitor, in type 2 diabetes mellitus patients: a pooled analysis of three randomised double-blind studiesNano-silver-decorated microfibrous eggshell membrane: processing, cytotoxicity assessment and optimization, antibacterial activity and wound healing.Luteolin reduces inflammation in Staphylococcus aureus-induced mastitis by inhibiting NF-kB activation and MMPs expression.Gene expression profile in delay graft function: inflammatory markers are associated with recipient and donor risk factorsTreatment of Muckle-Wells syndrome: analysis of two IL-1-blocking regimensDifferent Regulation of Interleukin-1 Production and Activity in Monocytes and Macrophages: Innate Memory as an Endogenous Mechanism of IL-1 Inhibition.Mx1 reveals innate pathways to antiviral resistance and lethal influenza diseaseSerum cytokine profile in pediatric Sweet's syndrome: a case report.Distinct lipid a moieties contribute to pathogen-induced site-specific vascular inflammation.Serine protease inhibition attenuates rIL-12-induced GZMA activity and proinflammatory events by modulating the Th2 profile from estrogen-treated mice.Gaucher iPSC-derived macrophages produce elevated levels of inflammatory mediators and serve as a new platform for therapeutic development.Disease severity in patients infected with Leishmania mexicana relates to IL-1β.Single nucleotide polymorphisms in IL1B and the risk of acute coronary syndrome: a Danish case-cohort study.Interleukin-1 signaling pathway as a therapeutic target in transthyretin amyloidosis.A 24-month open-label study of canakinumab in neonatal-onset multisystem inflammatory disease.Scropolioside B inhibits IL-1β and cytokines expression through NF-κB and inflammasome NLRP3 pathways.
P2860
Q21285000-B390E6BF-0119-4584-A74F-58E32726C99CQ26345196-8592A359-EB98-4DF8-AE97-49C3A34AD166Q26739670-CF8591E2-3A1D-4F93-8390-9EBD6587CA59Q27007734-DE5A1332-2EFD-4356-B2EA-01C6CEBD58FEQ27022093-DE4A8590-F861-429A-A827-541385445F35Q27322202-E8DC77E0-F139-495E-8F32-410E90FF516AQ28071417-3DD571A4-BAEA-49FA-A1D3-B82C9776390BQ28300967-21050505-E1A8-4D19-83B7-2D92858257D8Q28385724-7DBBCB42-89F5-43A2-B303-A55DD53312C8Q28397728-0B5D2FC9-5727-4542-8D5E-E9A8825D8A80Q28507530-71B6BEA5-68F2-49BB-B41B-19E9B99CBD9AQ28543791-78D8044C-073B-46AA-AB11-938542F52858Q28553088-E8D58EF7-18E1-4388-89A3-856913831667Q28659160-2363494D-6E7A-4FF9-A0D6-E8B5B0D83AFCQ30009577-542376FF-0CEA-435C-ABE7-50AA8D4E650AQ30355344-BED2C862-8774-42FB-829D-1315EAFC2529Q30358594-69EBEF76-E58D-428D-A98C-FE47E28523A5Q30414961-43CDBD21-567E-4DE9-B330-D5678500EA68Q30419673-3693E35F-F0B8-48A6-BFD8-094681B9AE44Q30429752-E8C4EA4C-B20E-4A7B-B74B-12DC0695310BQ30489641-C49EFBA4-53C5-4AAB-87B9-4FE1A19CFD57Q30855449-B854ECC8-C394-4C98-B433-7CB157FBA3BFQ33353321-807B0903-FA66-42A0-A758-EACB1094C8BAQ33585807-047A3047-8C8B-491C-AB76-0ACC4CF384D7Q33661359-F56BACF2-1AF6-4855-A8A0-41EC572E68CEQ33673376-2CCBF1EE-FEF7-49AC-9C7E-84AA4FC84929Q33709753-7FDFD8DC-9247-476B-9F86-8AEEA456070FQ33736225-46AA05A8-E5AC-4E5A-BAB7-2692E3B7329EQ33767097-984AD309-CE28-4386-B604-A2F8764BFED6Q33774843-40D94FC2-B180-42D3-99AF-D04DF4B053E2Q33782418-AAB8F7D9-A5C2-44C5-9A56-E5DDEC4B8B68Q33862602-8F4DB727-598C-4C18-B553-329A0B51C4EEQ33882825-26C632B3-3007-4A27-8191-092F3A72C1B7Q33901176-800A732A-9FB5-48ED-9353-C695BFE9C4A0Q34066863-D79B03E5-F927-4A69-A2A1-A674B469C255Q34282214-66C0921D-8BF1-48DD-B6A2-0544DF0BCAFBQ34327966-37E01059-D55F-4745-AB21-5AB64D102F76Q34336131-4CEAC34E-4178-4EA3-94FB-8C786FD86D14Q34423486-86561840-F1BB-4020-B1DB-97A1A35CB6B7Q34438283-9B9F8C31-CDB7-4DA6-AB5C-E22A8A21B0F8
P2860
A clinical perspective of IL-1β as the gatekeeper of inflammation.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on May 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
A clinical perspective of IL-1β as the gatekeeper of inflammation.
@en
A clinical perspective of IL-1β as the gatekeeper of inflammation.
@nl
type
label
A clinical perspective of IL-1β as the gatekeeper of inflammation.
@en
A clinical perspective of IL-1β as the gatekeeper of inflammation.
@nl
prefLabel
A clinical perspective of IL-1β as the gatekeeper of inflammation.
@en
A clinical perspective of IL-1β as the gatekeeper of inflammation.
@nl
P356
P1476
A clinical perspective of IL-1β as the gatekeeper of inflammation.
@en
P304
P356
10.1002/EJI.201141550
P407
P577
2011-05-01T00:00:00Z